0.74 USD
↘ 0.05 (6.64%)AT CLOSE (03:59 PM EDT)
Alaunos Therapeutics, Inc. Common Stock
TCRTNASDAQ • USD
0.75
↗ 0.00 (0.48%)
POST MARKET (AS OF 05:32 PM EDT)
Post Market
AS OF 05:32 PM EDT
0.75
↗ 0.00 (0.48%)
Market: OPEN
Shares of Alaunos Therapeutics, Inc. Common Stock (TCRT) are trading at $0.75. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 6, 2026.
Open?$0.79
High?$0.82
Low?$0.72
Prev. Close?$0.80
Volume?121.1K
Avg. Volume?1.7M
VWAP?$0.76
Rel. Volume?0.07x
Bid / Ask
Bid?$0.63 × 100
Ask?$0.90 × 100
Spread?$0.27
Midpoint?$0.77
Valuation & Ratios
Market Cap?2.0M
Shares Out?2.5M
Float?19.0M
Float %?77.7%
P/E Ratio?N/A
P/B Ratio?3.12
EPS?-$1.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
Address
501 E LAS OLAS BLVD
FORT LAUDERDALE, FL 33301
Phone: (346) 355-4099
FORT LAUDERDALE, FL 33301
Phone: (346) 355-4099
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?-863.26Distress
Confidence?49%Low
Short InterestLow
Short % of Float?0.03%Low
Short Interest?6.1K
Days to Cover?1.0
Free Float19.0M
Avg Daily Volume10.3K
Settlement Date2026-09-15
Financial Health
Current Ratio?0.77Weak
Quick Ratio?0.77Weak
Cash Ratio?0.14Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.12FAIR▾
Peers100
S&P54
P/S?677.46HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?636.13HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-654.1%WEAK▾
S&P3
ROA?-281.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-2825000
Enterprise Value?$1.9M
Fundamentals ratios updated end of day